Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 4951 AL 4965

Genome-wide significant, replicated and functional risk variants for Alzheimer's disease

Guo X, Qiu W, Garcia-Milian R, Lin X, Zhang Y, Cao Y, Tan Y, Wang Z, Shi J, Wang J, Liu D, Song L, Xu Y, Wang X, Liu N, Sun T, Zheng J, Luo J, Zhang H, Xu J, Kang L, Ma C, Wang K, Luo X.

J Neural Transm (Vienna). 2017 Nov;124(11):1455-1471. doi: 10.1007/s00702-017-1773-0. Epub 2017 Aug 2.

Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease

Prickaerts J, Heckman PRA, Blokland A.

Expert Opin Investig Drugs. 2017 Sep;26(9):1033-1048. doi: 10.1080/13543784.2017.1364360. Epub 2017 Aug 9.

Is functional mobility an independent mortality risk factor in subjects with dementia?

Mahmoudi R, Novella JL, Manckoundia P, Ahssaini F, Lang PO, Blanchard F, Jolly D, Dramé M.

Maturitas. 2017 Sep;103:65-70. doi: 10.1016/j.maturitas.2017.06.031. Epub 2017 Jul 3.

Cognitive Issues: Decline, Delirium, Depression, Dementia

Harris M.

Nurs Clin North Am. 2017 Sep;52(3):363-374. doi: 10.1016/j.cnur.2017.05.001.

Observational study of vascular dementia in the Spanish elderly population according to type 2 diabetes status: trends in incidence, characteristics and outcomes (2004-2013)

Muñoz-Rivas N, Méndez-Bailón M, Miguel-Yanes JM, Hernández-Barrera V, Miguel-Díez J, Jimenez-Garcia R, López-de-Andrés A.

BMJ Open. 2017 Aug 4;7(8):e016390. doi: 10.1136/bmjopen-2017-016390.

Rollercoaster Blood Pressure: An Alzheimer Disease Risk Factor?

Merkler AE, Iadecola C.

Circulation. 2017 Aug 8;136(6):526-528. doi: 10.1161/CIRCULATIONAHA.117.029618.

Pharmacotherapy for Vascular Cognitive Impairment

Farooq MU, Min J, Goshgarian C, Gorelick PB.

CNS Drugs. 2017 Sep;31(9):759-776. doi: 10.1007/s40263-017-0459-3.

Effectiveness of Florbetapir PET Imaging in Changing Patient Management

Pontecorvo MJ, Siderowf A, Dubois B, Doraiswamy PM, Frisoni GB, Grundman M, Nobili F, Sadowsky CH, Salloway S, Arora AK, Chevrette A, Deberdt W, Dell'Agnello G, Flitter M, Galante N, Lowrey MJ, Lu M, McGeehan A, Devous MD Sr, Mintun MA.

Dement Geriatr Cogn Disord. 2017;44(3-4):129-143. doi: 10.1159/000478007. Epub 2017 Aug 5.

Apathy: Risk Factor for Mortality in Nursing Home Patients

Nijsten JMH, Leontjevas R, Pat-El R, Smalbrugge M, Koopmans RTCM, Gerritsen DL.

J Am Geriatr Soc. 2017 Oct;65(10):2182-2189. doi: 10.1111/jgs.15007. Epub 2017 Aug 9.

Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: A systematically conducted narrative review

Yang F, Dawes P, Leroi I, Gannon B.

Int J Geriatr Psychiatry. 2018 Feb;33(2):e166-e176. doi: 10.1002/gps.4771. Epub 2017 Aug 10.

Dementia for the Primary Care Provider

Moga DC, Roberts M, Jicha G.

Prim Care. 2017 Sep;44(3):439-456. doi: 10.1016/j.pop.2017.04.005.

Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia

Stephan BCM, Harrison SL, Keage HAD, Babateen A, Robinson L, Siervo M.

Curr Cardiol Rep. 2017 Aug 11;19(9):87. doi: 10.1007/s11886-017-0898-y.

Relationship between atrial fibrillation and cognitive decline in individuals aged 80 and older

Proietti M, Recchia A, Riva E, Lucca U, Tettamanti M, Mannucci PM, Nobili A.

Eur J Intern Med. 2017 Dec;46:6-10. doi: 10.1016/j.ejim.2017.08.010. Epub 2017 Aug 9.

PERK as a hub of multiple pathogenic pathways leading to memory deficits and neurodegeneration in Alzheimer's disease

Ohno M.

Brain Res Bull. 2018 Jul;141:72-78. doi: 10.1016/j.brainresbull.2017.08.007. Epub 2017 Aug 10.

Managing Faecal INcontinence in people with advanced dementia resident in Care Homes (FINCH) study: a realist synthesis of the evidence

Goodman C, Norton C, Buswell M, Russell B, Harari D, Harwood R, Roe B, Rycroft-Malone J, Drennan VM, Fader M, Maden M, Cummings K, Bunn F.

Health Technol Assess. 2017 Aug;21(42):1-220. doi: 10.3310/hta21420.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias